Skip to content

EDMONd - Elemental Diet in Bowel Obstruction

A Feasibility Study of Elemental Diet as an Alternative to Parenteral Nutrition for Patients With Inoperable Malignant Bowel Obstruction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03150992
Acronym
EDMONd
Enrollment
34
Registered
2017-05-12
Start date
2017-07-19
Completion date
2019-12-31
Last updated
2019-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Neoplasm, Bowel Obstruction, Metastatic Ovarian Cancer, Ovarian Cancer, Ovarian Disease, Ovarian Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Primary Peritoneal Carcinoma

Keywords

Feasibility, Elemental Diet, Quality of life, Palliative, Nutrition, Ovarian, Peritoneal, Advanced, Metastatic, Bowel obstruction, Inoperable

Brief summary

A feasibility study to provide 'proof of concept' of Elemental Diet (ED) as an acceptable/ useful feeding option for patient with inoperable malignant bowel obstruction and to examine the impact of ED on quality of life

Detailed description

The aim of this study is to determine whether Elemental Diet (a type of drink that contains an elemental protein source known as amino acids) can be tolerated by patients with inoperable bowel blockage who can no longer eat and are only able to swallow small amount of fluid. The objective is to find out whether elemental diet (ED) can be used as an acceptable nutrition and whether it improves the quality of life. Bowel blockage is a common complication in patients with ovarian cancer. Unfortunately when the cancer is advanced, this blockage can occur in many parts of the bowel therefore surgery is not possible. Every year in the UK some publications report the rate as high as 50% . One way to feed patients with bowel blockage is through the veins; this is known as parenteral nutrition (PN) however PN is rarely used in United Kingdom. Patients with malignant bowel blockage are often able to swallow small amounts of liquid but if they have no PN they are only able to survive for 2-3 weeks and the psychological as well as physical impact on patients and the family are very distressing. ED is a type of a drink which contains an elemental protein source known as amino acids. ED drinks are almost totally absorbed in the upper part of the bowel and therefore could be absorbed even in patients who have bowel blockage which usually develops lower down in the gut. If this study is successful and proves that ED can be tolerated and provide nutrition to patients with inoperable bowel blockage it will be a big step towards improving the quality of life at the final stage of cancer.

Interventions

DIETARY_SUPPLEMENTElemental 028 Extra Liquid

A nutritionally complete, liquid elemental diet consisting of a mixture of essential and non-essential amino acids, carbohydrate, fat, vitamins, minerals, trace elements and flavourings with sugars & sweeteners.

Sponsors

University of Surrey
CollaboratorOTHER
Target Ovarian Cancer
CollaboratorUNKNOWN
Royal Surrey County Hospital NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Confirmed inoperable bowel obstruction due to disseminated malignancy * Ability to tolerate 500ml of liquid * Capacity to give informed consent

Exclusion criteria

* Bowel obstruction that can be managed with surgical intervention * Complete bowel obstruction and inability to tolerate small amount of liquid

Design outcomes

Primary

MeasureTime frameDescription
Taste acceptability of EDTwo weeksTaste of at least one flavor of ED graded as 2 out of 5 by patient on nutritional diary taste acceptability scale (1=I really like the taste, 2=I like the taste, 3=The taste is acceptable, 4=I do not like the taste but can drink it, 5=I do not like the taste and cannot drink it).
Change in incidence of vomitingTwo weeksNo deterioration in incidence of vomiting as measured on MSAS scale. Grading 1 (occurring rarely) or 2 (occurring occasionally) is acceptable. Deterioration considered as change to 3 (occurring frequently) or 4 (occurring almost constantly).
Change in incidence of painTwo weeksNo deterioration in incidence of abdominal pain as measured on MSAS scale. Grading 1 (occurring rarely) or 2 (occurring occasionally) is acceptable. Deterioration considered as change to 3 (occurring frequently) or 4 (occurring almost constantly).

Secondary

MeasureTime frameDescription
Nutritional intakeTwo weeksMeasured by number of cartons taken by patient in 24 hours
Health related quality of lifeTwo weeksMeasured on EORTC-QLQ-C30
The number of patients who can tolerate ED following presentation with IBO and can subsequently be treated with palliative chemotherapyTwo weeksMeasured by reviewing hospital case notes
Number of patients alive at the end of the studyUp to two yearsMeasured by reviewing hospital case notes

Countries

United Kingdom

Contacts

Primary ContactEleanor Smith
eleanor.smith@surrey.ac.uk01483 688547

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026